LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 823

Search options

  1. Book: The difficult patient in gastroenterology and hepatology

    Tack, Jan

    (Best practice & research : Clinical gastroenterology ; 21,3)

    2007  

    Author's details J. Tack ..., guest ed
    Series title Best practice & research : Clinical gastroenterology ; 21,3
    Best practice & research
    Best practice & research ; Clinical gastroenterology
    Collection Best practice & research
    Best practice & research ; Clinical gastroenterology
    Language English
    Size S. 365 - 560 : Ill., graph. Darst.
    Publisher Elsevier
    Publishing place Amsterdam
    Publishing country Netherlands
    Document type Book
    HBZ-ID HT015255641
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  2. Article ; Online: Is the Quantification of Interstitial Cells of Cajal in Gastric Biopsy Samples in Patients With Gastroparesis Ready for Prime Time?

    Camilleri, Michael / Tack, Jan

    Gastroenterology

    2023  Volume 165, Issue 1, Page(s) 1–4

    MeSH term(s) Humans ; Gastroparesis/diagnosis ; Gastroparesis/pathology ; Interstitial Cells of Cajal/pathology ; Gastric Emptying ; Biopsy
    Language English
    Publishing date 2023-03-16
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80112-4
    ISSN 1528-0012 ; 0016-5085
    ISSN (online) 1528-0012
    ISSN 0016-5085
    DOI 10.1053/j.gastro.2023.03.204
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Book: Functional gastrointestinal disorders

    Tack, Jan

    (Best practice & research clinical gastroenterology ; 18,4)

    2004  

    Author's details J. Tack, guest ed
    Series title Best practice & research clinical gastroenterology ; 18,4
    Best practice & research
    Collection Best practice & research
    Language English
    Size S. 611 - 796 : Ill., graph. Darst.
    Publisher Baillière Tindall
    Publishing place London u.a.
    Publishing country Great Britain
    Document type Book
    HBZ-ID HT014127807
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  4. Book: A guide to gastrointestinal motility disorders

    Bredenoord, Albert J. / Smout, André / Tack, Jan

    2016  

    Author's details Albert J. Bredenoord ; André Smout ; Jan Tack
    Keywords manometry ; gastroesophageal reflux ; dyspepsia ; abdominal pain ; constipation
    Language English
    Size VIII, 112 S. : Ill., graph. Darst.
    Publisher Springer
    Publishing place Cham u.a.
    Publishing country Switzerland
    Document type Book
    HBZ-ID HT018877573
    ISBN 978-3-319-26936-8 ; 978-3-319-26938-2 ; 3-319-26936-4 ; 3-319-26938-0
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  5. Article: Editorial.

    Tack, Jan

    United European gastroenterology journal

    2018  Volume 6, Issue 10, Page(s) 1447

    Language English
    Publishing date 2018-11-29
    Publishing country England
    Document type Editorial
    ISSN 2050-6406
    ISSN 2050-6406
    DOI 10.1177/2045125318814098
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Comments on the use of confocal laser endomicroscopy in diagnosing protein-losing enteropathy.

    Balsiger, Lukas Michaja / Tack, Jan / Simrén, Magnus / van Gils, Tom

    Endoscopy

    2024  Volume 56, Issue 2, Page(s) 158

    MeSH term(s) Humans ; Protein-Losing Enteropathies/diagnosis ; Protein-Losing Enteropathies/etiology ; Endoscopy ; Contrast Media ; Lasers ; Microscopy, Confocal
    Chemical Substances Contrast Media
    Language English
    Publishing date 2024-01-30
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 80120-3
    ISSN 1438-8812 ; 0013-726X
    ISSN (online) 1438-8812
    ISSN 0013-726X
    DOI 10.1055/a-2205-3037
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: The Role of Food in Disorders of Gut-Brain Interaction: Introduction to a Rome Foundation Working Group Series.

    Chey, William D / Tack, Jan

    The American journal of gastroenterology

    2022  Volume 117, Issue 6, Page(s) 935–936

    MeSH term(s) Brain/diagnostic imaging ; Food ; Gastrointestinal Diseases ; Humans ; Rome
    Language English
    Publishing date 2022-03-23
    Publishing country United States
    Document type Journal Article
    ZDB-ID 390122-1
    ISSN 1572-0241 ; 0002-9270
    ISSN (online) 1572-0241
    ISSN 0002-9270
    DOI 10.14309/ajg.0000000000001744
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Editorial: refractory reflux sensitivity-A place for baclofen? Authors' reply.

    Raymenants, Karlien / Tack, Jan

    Alimentary pharmacology & therapeutics

    2022  Volume 56, Issue 4, Page(s) 725–726

    MeSH term(s) Baclofen/therapeutic use ; Esophagitis, Peptic ; Gastroesophageal Reflux/diagnosis ; Gastroesophageal Reflux/drug therapy ; Humans
    Chemical Substances Baclofen (H789N3FKE8)
    Language English
    Publishing date 2022-07-26
    Publishing country England
    Document type Editorial ; Comment
    ZDB-ID 639012-2
    ISSN 1365-2036 ; 0269-2813 ; 0953-0673
    ISSN (online) 1365-2036
    ISSN 0269-2813 ; 0953-0673
    DOI 10.1111/apt.17129
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Patient-Reported Outcomes in Disorders of Gut-Brain Interaction.

    Tack, Jan / Carbone, Florencia / Chang, Lin / Lacy, Brian E

    Gastroenterology

    2024  Volume 166, Issue 4, Page(s) 572–587.e1

    Abstract: Disorders of gut-brain interaction are characterized by chronic gastrointestinal symptoms in the absence of abnormal endoscopic or radiologic findings or objective biomarkers that can be identified during routine clinical evaluation. The assessment of ... ...

    Abstract Disorders of gut-brain interaction are characterized by chronic gastrointestinal symptoms in the absence of abnormal endoscopic or radiologic findings or objective biomarkers that can be identified during routine clinical evaluation. The assessment of the symptom pattern and severity, therefore, is the key modality to evaluate the presence, impact, and evolution of these conditions, for both clinical and regulatory purposes. Patient-reported outcomes are structured symptom assessment questionnaires designed to evaluate symptom patterns, quantify severity of symptoms, and evaluate response to treatment at follow-up. This review provides an overview of currently available patient-reported outcomes for evaluating the main disorders of gut-brain interaction, specifically, functional dyspepsia; irritable bowel syndrome; and chronic constipation. It summarizes their content, level of validation for clinical practice and for research, and the regulatory approach to these conditions. Expected future developments and need for further research on patient-reported outcomes for these and other disorders of gut-brain interaction are highlighted.
    MeSH term(s) Humans ; Irritable Bowel Syndrome/diagnosis ; Irritable Bowel Syndrome/therapy ; Gastrointestinal Diseases/diagnosis ; Gastrointestinal Diseases/therapy ; Dyspepsia ; Constipation ; Brain/diagnostic imaging ; Patient Reported Outcome Measures
    Language English
    Publishing date 2024-02-01
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 80112-4
    ISSN 1528-0012 ; 0016-5085
    ISSN (online) 1528-0012
    ISSN 0016-5085
    DOI 10.1053/j.gastro.2023.11.307
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Tegaserod: What's Old Is New Again.

    Sayuk, Gregory S / Tack, Jan

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

    2022  Volume 20, Issue 10, Page(s) 2175–2184.e19

    Abstract: Irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) are common gastrointestinal disorders imposing considerable impact on the quality of life and well-being of affected individuals. A paucity of evidence-based ... ...

    Abstract Irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) are common gastrointestinal disorders imposing considerable impact on the quality of life and well-being of affected individuals. A paucity of evidence-based treatment options exist for CIC and IBS-C sufferers. Tegaserod, a 5-HT<sub>4</sub> agonist, has a substantial body of preclinical and clinical study evidence to support its beneficial role in modulating sensorimotor function of the luminal gastrointestinal tract. Tegaserod was first approved for use by the U.S. Food and Drug Administration for the management of IBS-C and CIC in 2002 and 2004, respectively. Tegaserod enjoyed a successful uptake in the management of these disorders during its first several years of availability in the United States, but was later withdrawn from the market in 2007 over concerns related to adverse cardiovascular events. Since then, additional safety data has been generated, and following a resubmission and review by the Food and Drug Administration, in April 2019, tegaserod was once again approved for use in IBS-C under a more restricted labeling, confining use to women under 65 years of age without heart disease or additional cardiovascular risk factors. This review summarizes the regulatory journey of tegaserod and details the existing pharmacokinetic, physiologic, clinical, and safety data of tegaserod generated over the last 2 decades. The discussion also examines the future of tegaserod in the treatment of these constipation disorders, as well as its potential role in other related disorders of brain-gut interaction.
    MeSH term(s) Constipation/drug therapy ; Female ; Gastrointestinal Agents/adverse effects ; Humans ; Indoles ; Irritable Bowel Syndrome/drug therapy ; Quality of Life ; Serotonin/therapeutic use ; Serotonin Receptor Agonists/therapeutic use
    Chemical Substances Gastrointestinal Agents ; Indoles ; Serotonin Receptor Agonists ; Serotonin (333DO1RDJY) ; tegaserod (458VC51857)
    Language English
    Publishing date 2022-02-02
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2119789-1
    ISSN 1542-7714 ; 1542-3565
    ISSN (online) 1542-7714
    ISSN 1542-3565
    DOI 10.1016/j.cgh.2022.01.024
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top